📈 What is the 5 mg dose?
• Zepbound (tirzepatide) is a weekly injectable for chronic weight management in adults with obesity or overweight plus comorbidities—also approved for moderate-to-severe obstructive sleep apnea (OSA) .
• After starting at 2.5 mg weekly for four weeks, you advance to 5 mg weekly, which begins the maintenance phase for most users seeking weight loss .
🌟 Role of 5 mg in therapy
• Transition dose: 5 mg marks the shift from initiation to potential maintenance.
• Maintenance efficacy:
• Clinical data show ~15% average weight loss at 5 mg over 72 weeks ().
• For many, 5 mg sustains satisfactory results; for others, increases up to 15 mg may be considered if needed .
⸻
💊 How dosing progresses
1. Weeks 1–4: 2.5 mg to initiate therapy.
2. Week 5 onward: Move to 5 mg weekly.
3. Every 4+ weeks thereafter: Option to bump up by 2.5 mg to 7.5, 10, 12.5, up to 15 mg, guided by tolerability and goals
